[PDF][PDF] α cell function and gene expression are compromised in type 1 diabetes

M Brissova, R Haliyur, D Saunders, S Shrestha, C Dai… - Cell reports, 2018 - cell.com
M Brissova, R Haliyur, D Saunders, S Shrestha, C Dai, DM Blodgett, R Bottino…
Cell reports, 2018cell.com
Many patients with type 1 diabetes (T1D) have residual β cells producing small amounts of
C-peptide long after disease onset but develop an inadequate glucagon response to
hypoglycemia following T1D diagnosis. The features of these residual β cells and α cells in
the islet endocrine compartment are largely unknown, due to the difficulty of comprehensive
investigation. By studying the T1D pancreas and isolated islets, we show that remnant β
cells appeared to maintain several aspects of regulated insulin secretion. However, the …
Summary
Many patients with type 1 diabetes (T1D) have residual β cells producing small amounts of C-peptide long after disease onset but develop an inadequate glucagon response to hypoglycemia following T1D diagnosis. The features of these residual β cells and α cells in the islet endocrine compartment are largely unknown, due to the difficulty of comprehensive investigation. By studying the T1D pancreas and isolated islets, we show that remnant β cells appeared to maintain several aspects of regulated insulin secretion. However, the function of T1D α cells was markedly reduced, and these cells had alterations in transcription factors constituting α and β cell identity. In the native pancreas and after placing the T1D islets into a non-autoimmune, normoglycemic in vivo environment, there was no evidence of α-to-β cell conversion. These results suggest an explanation for the disordered T1D counterregulatory glucagon response to hypoglycemia.
cell.com